Cleared Traditional

K250688 - Cedar Endovenous Radiofrequency Cathete...

Also marketed or referenced as:
Cedar™ Endovenous Radiofrequency Catheter (ERA-C30-US) Endovenous Radiofrequency Generator (ERA-G5-US)

K250688 is an FDA 510(k) clearance for Cedar Endovenous Radiofrequency Cathete..., manufactured by Acotec Scientific Co., Ltd.. The device is a Class 2 General & Plastic Surgery device with product code GEI cleared through the Traditional 510(k) pathway after a 215-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2025
Decision
215d
Days
Class 2
Risk

K250688 is an FDA 510(k) clearance for the Cedar™ Endovenous Radiofrequency Catheter (ERA-C70-US). Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Acotec Scientific Co., Ltd. (Beijing, CN). The FDA issued a Cleared decision on October 7, 2025 after a review of 215 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Acotec Scientific Co., Ltd. devices

FDA 510(k) Submission Details - K250688

510(k) Number K250688 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2025
Decision Date October 07, 2025
Days to Decision 215 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 115d · This submission: 215d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEI Device Classification - Class 2, Special Controls

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Fabrica Consulting, LLC
Sara Toyloy

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1257
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K250688.
ArtiSeal Vessel Sealing System - ArtiSeal Instruments (AS01M)
K250126 · Livsmed, Inc. · Oct 2025
Coolfase
K250852 · Asterasys Co., Ltd. · Oct 2025
InbellaMulti System
K252367 · Inbella Medical, Inc. · Oct 2025
Ultrasonic Bipolar Generator (USG-410)
K252150 · Olympus Medical Systems Corporation · Oct 2025
E Blator
K251899 · New Deantronics Taiwan , Ltd. · Oct 2025
NEW DOUBLO 2.0
K251334 · Hironic Co., Ltd. · Sep 2025